Business
FutureGen Industries Provides Investment Performance Update and Shares Realized Gains
VANCOUVER, BC / ACCESS Newswire / March 1, 2026 / FutureGen Industries Corp. (TSXV: LITT ) (fo...
About this update from Futuregen Industries Corp.
[{"type":"text","content":"FutureGen Industries Provides Investment Performance Update and Shares Realized GainsVANCOUVER, BC / ACCESS Newswire / March 1, 2026 / FutureGen Industries Corp. (TSXV:LITT) (formerly Right Season Investments Corp.) (Frankfurt:T500, WKN: A41WY4) (\"FutureGen Industries\" or the \"Company\") is pleased to report notable realized gains from recent strategic portfolio activity. These results reflect the Company's ongoing efforts to identify opportunities and generate value through its disciplined investment approach.Onco-Innovations (CBOE CA: ONCO) Investment Update:FutureGen Industries invested $31,175 into Onco-Innovations Limited (CBOE CA: ONCO) in June 2025. During 2025, the Company sold 500,000 shares, generating realized gains of $765,065.33. Onco-Innovations is a Canadian biotechnology company dedicated to advancing precision-driven solutions for cancer treatment. The company's research focuses on developing PNKP-inhibitor therapies that target a key DNA repair mechanism relied upon by solid tumours. By selectively impairing this pathway, the technology is designed to increase the vulnerability of cancer cells to existing treatment modalities while helping safeguard surrounding healthy tissue. With exclusive global rights to its therapeutic platform and a commitment to improving patient outcomes, Onco-Innovations continues to progress its development work and build the scientific foundation supporting its approach.ASEP Medical Holdings Inc. Investment Update:On November 14, 2022, FutureGen Industries made an investment in privately held Safecoat Medical Inc. (\"Safecoat\") by acquiring 500,000 common shares at an average cost of $0.0231 per share. Following Safecoat's earn-in and option agreement with ASEP Medical Holdings Inc. (\"ASEP\"), ASEP acquired a 50.1 percent interest in Safecoat. FutureGen Industries received 461,400 common shares of ASEP at a deemed value of $0.20 per share in exchange for its Safecoat shares. During 2025, the Company sold 346,050 ASEP shares, generating realized gains of $118,255.57.ASEP Medical Holdings Inc. is advancing technologies aimed at addressing antibiotic failure and improving outcomes for patients facing serious infections. The company is developing a rapid diagnostic platform designed to support earlier detection of sepsis, a condition affecting millions worldwide and associated with ...